Podcasts about Bone marrow

Joao wants to know what happens when stem cells of our own, which have been cultivated outside the body, are reintroduced to the bloodstream. This got James Tytko thinking about autologous stem cell transplants, used as a treatment for some forms of blood cancer. He asked Tania Dexter, haematology registrar, and senior medical officer at the Anthony Nolan Institute, to help explain... Like this podcast? Please help us by supporting the Naked Scientists

In this episode of the Veterinary Cancer Pioneers Podcast, host Dr. Rachel Venable speaks with Dr. Steve Suter, a trailblazer in canine bone marrow transplantation, about his unexpected path into transplant research and the launch of the world's only academic bone marrow transplant program for dogs. Dr. Suter discusses the differences between autologous and allogeneic transplants, clinical protocols, and the emotional and logistical challenges behind this advanced treatment for canine lymphoma and leukemia. They delve into powerful case stories, donor matching hurdles, and the growing importance of early intervention and immunotherapy in veterinary oncology. Tune in to hear how Dr. Suter is reshaping cancer care for dogs—and why bone marrow transplants may offer new hope where traditional chemotherapy falls short.

We begin this broadcast with Project 44. Beloved member of the Butler Basketball national championship teams, #44 Andrew Smith, passed away at the age of 25 from a rare bone cancer. In Andrew's name, Project 44 launched in 2016 to advocate for Bone Marrow donations and Cancer Awareness, Funding, and Research. You can learn more […]

In today's show: The news of the day; Czech family's plea for bone marrow donor sparks nationwide response; bringing global and space phenomena to life in Žatec; and for our feature, we have Jakub Ferenčík's interview with Lea-Ann Germinder an AI researcher on Czech-US alignment in AI regulation, and more.

In today's show: The news of the day; Czech family's plea for bone marrow donor sparks nationwide response; bringing global and space phenomena to life in Žatec; and for our feature, we have Jakub Ferenčík's interview with Lea-Ann Germinder an AI researcher on Czech-US alignment in AI regulation, and more.

Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances, discusses a recently published original research paper on Effect of Sacubitril/Valsartan or Enalapril on Left Ventricular Function in Patients With Hematologic Malignancies Treated With Bone Marrow Transplantation: A Randomized Controlled Trial

Explore the cutting-edge intersection of space travel, biology, and health. Experts dive into the effects of microgravity and space radiation on mitochondrial function, DNA repair, and liver regeneration, shedding light on the unique challenges astronauts face during long-term missions. The discussion also touches on metabolic health, highlighting the role of diet and new pharmaceutical treatments like GLP-1 agonists in addressing modern-day health concerns. With engaging insights on how space research can inform breakthroughs on Earth, this talk is a must-watch for anyone interested in the future of human health and space exploration. Series: "MIND - Medicine Informing Novel Discoveries" [Health and Medicine] [Science] [Show ID: 40388]

Explore the cutting-edge intersection of space travel, biology, and health. Experts dive into the effects of microgravity and space radiation on mitochondrial function, DNA repair, and liver regeneration, shedding light on the unique challenges astronauts face during long-term missions. The discussion also touches on metabolic health, highlighting the role of diet and new pharmaceutical treatments like GLP-1 agonists in addressing modern-day health concerns. With engaging insights on how space research can inform breakthroughs on Earth, this talk is a must-watch for anyone interested in the future of human health and space exploration. Series: "MIND - Medicine Informing Novel Discoveries" [Health and Medicine] [Science] [Show ID: 40388]

Explore the cutting-edge intersection of space travel, biology, and health. Experts dive into the effects of microgravity and space radiation on mitochondrial function, DNA repair, and liver regeneration, shedding light on the unique challenges astronauts face during long-term missions. The discussion also touches on metabolic health, highlighting the role of diet and new pharmaceutical treatments like GLP-1 agonists in addressing modern-day health concerns. With engaging insights on how space research can inform breakthroughs on Earth, this talk is a must-watch for anyone interested in the future of human health and space exploration. Series: "MIND - Medicine Informing Novel Discoveries" [Health and Medicine] [Science] [Show ID: 40388]

Explore the cutting-edge intersection of space travel, biology, and health. Experts dive into the effects of microgravity and space radiation on mitochondrial function, DNA repair, and liver regeneration, shedding light on the unique challenges astronauts face during long-term missions. The discussion also touches on metabolic health, highlighting the role of diet and new pharmaceutical treatments like GLP-1 agonists in addressing modern-day health concerns. With engaging insights on how space research can inform breakthroughs on Earth, this talk is a must-watch for anyone interested in the future of human health and space exploration. Series: "MIND - Medicine Informing Novel Discoveries" [Health and Medicine] [Science] [Show ID: 40388]

Explore the cutting-edge intersection of space travel, biology, and health. Experts dive into the effects of microgravity and space radiation on mitochondrial function, DNA repair, and liver regeneration, shedding light on the unique challenges astronauts face during long-term missions. The discussion also touches on metabolic health, highlighting the role of diet and new pharmaceutical treatments like GLP-1 agonists in addressing modern-day health concerns. With engaging insights on how space research can inform breakthroughs on Earth, this talk is a must-watch for anyone interested in the future of human health and space exploration. Series: "MIND - Medicine Informing Novel Discoveries" [Health and Medicine] [Science] [Show ID: 40388]

Explore the cutting-edge intersection of space travel, biology, and health. Experts dive into the effects of microgravity and space radiation on mitochondrial function, DNA repair, and liver regeneration, shedding light on the unique challenges astronauts face during long-term missions. The discussion also touches on metabolic health, highlighting the role of diet and new pharmaceutical treatments like GLP-1 agonists in addressing modern-day health concerns. With engaging insights on how space research can inform breakthroughs on Earth, this talk is a must-watch for anyone interested in the future of human health and space exploration. Series: "MIND - Medicine Informing Novel Discoveries" [Health and Medicine] [Science] [Show ID: 40388]

Explore the cutting-edge intersection of space travel, biology, and health. Experts dive into the effects of microgravity and space radiation on mitochondrial function, DNA repair, and liver regeneration, shedding light on the unique challenges astronauts face during long-term missions. The discussion also touches on metabolic health, highlighting the role of diet and new pharmaceutical treatments like GLP-1 agonists in addressing modern-day health concerns. With engaging insights on how space research can inform breakthroughs on Earth, this talk is a must-watch for anyone interested in the future of human health and space exploration. Series: "MIND - Medicine Informing Novel Discoveries" [Health and Medicine] [Science] [Show ID: 40388]

Explore the cutting-edge intersection of space travel, biology, and health. Experts dive into the effects of microgravity and space radiation on mitochondrial function, DNA repair, and liver regeneration, shedding light on the unique challenges astronauts face during long-term missions. The discussion also touches on metabolic health, highlighting the role of diet and new pharmaceutical treatments like GLP-1 agonists in addressing modern-day health concerns. With engaging insights on how space research can inform breakthroughs on Earth, this talk is a must-watch for anyone interested in the future of human health and space exploration. Series: "MIND - Medicine Informing Novel Discoveries" [Health and Medicine] [Science] [Show ID: 40388]

EXCLUSIVE NordVPN Deal ➼ https://nordvpn.com/bluemoon Try it risk-free now with a 30-day money-back guarantee! ========== After a week that suggests signs of improved consistency (even if the results weren't all positive), David Mooney is joined by Manchester City fans Adam Monk and Chris Higginbottom to discuss the games with Liverpool and Spurs. They look at how the new signings are settling in - especially Abdukodir Khusanov - and how they have helped the performances this week. Plus, they look at the VAR decision NOT to award Erling Haaland's second goal at Spurs and the protocols behind why it wasn't given. With all-conquering Plymouth up next in the FA Cup, we hear from Aaron Hocking from Argyle Life. He explains what to expect from The Pilgrims on Saturday, as they look to make City their third Premier League victims of their cup run. Former City striker Robert Taylor is also on the show - he's discussing playing AGAINST City for Gillingham at Wembley in 1999, before switching to Maine Road as City pushed for back-to-back promotions. ========== To get more podcasts or to listen without the ads, join our Patreon. It's just £2 per month for all the extra content and you can get a 7-day free trial first: https://www.patreon.com/BlueMoonPodcast And why not gift a Patreon subscription to a friend or family member? More details: https://www.patreon.com/BlueMoonPodcast/gift

Dillon only enjoys his mezcal out of bones now, the chances of earth being hit my an asteroid are rising, a farewell to our affair with Montoya, recapping White Lotus Season 3 Episode 1, the Drake drone video that may be staged, and This Weekend in Fun. Enjoy a free one-week trial on Patreon for additional weekly episodes: www.patreon.com/circlingbackpodcast Watch all of our full episodes on our new YouTube channel: www.youtube.com/circlingback  Shop Washed Merch: www.washedmedia.shop  (0:00) Fun & Easy Banter (4:15) Impromptu Space Bar: Asteroid Chances (15:30) Are we drinking mezcal out of bones?? (27:15) Closing the book on Montoya (32:12) White Lotus, S3E1 (44:00) Drake Drone Video (56:42) This Weekend in Fun Support This Episode's Sponsors Rhoback: www.rhoback.com (WASHED20 for 20% off) Shopify: www.shopify.com/circling  Huel:Get Huel today with this exclusive offer for New Customers of 15% OFF + a FREE Gift with a minimum $75 purchase at https://www.huel.com  Learn more about your ad choices. Visit megaphone.fm/adchoices

Send us a textKevin Caldwell is CEO, Co-Founder & President of Ossium Health ( https://ossiumhealth.com/ ), a commercial stage bioengineering company that leverages its proprietary organ donor bone marrow banking platform to develop stem cell therapies for patients with life-threatening hematologic conditions, organ transplant rejection, and musculoskeletal defects.  Mr. Caldwell built Ossium from a small startup into the clinical stage bioengineering company it is today, setting the company's mission to improve human health through bioengineering and designed its platform-based model for cellular therapeutics development. He has led the company's successful pursuit, negotiation, and execution of more than 50 business relationships, including 5 successful fundraisings and dozens of supply partnerships, clinical partnerships, and commercial contracts with biopharmaceutical companies. After seven years of strategic engagement and networking, Mr. Caldwell drove the team to successfully secure a transformative federal contract with BARDA (Biomedical Advanced Research and Development Authority) that validates Ossium's innovative approach. This milestone represents the culmination of persistent relationship-building, targeted proposals, and  unwavering commitment to addressing national biomedical challenges through cutting-edge technology and collaborative partnerships.Prior to founding Ossium, Mr. Caldwell served as an Engagement Manager at McKinsey's San Francisco office where he advised clients in the biotechnology and healthcare sectors. His projects ranged from due diligence of acquisition targets in the biotech startup ecosystem to restructuring distressed biopharma companies. Mr. Caldwell led more than 20 engagements with more than a dozen clients, leading teams that advised clients on revenue growth, go to market strategy, and organizational restructuring.Before McKinsey, Mr. Caldwell served as a Senior Investment Associate at Bridgewater Associates where he did quantitative research for the firm's global macro investments. Mr. Caldwell studied Physics and Economics at MIT before receiving his JD from Harvard Law School. In addition, he is a member of the Young Presidents Organization (YPO), and a Fellow of the Leaders in Tech Program.#KevinCaldwell #OssiumHealth #BoneMarrow #HematopoieticStemCellTransplantation #HSCT #MesenchymalStemCells #Leukemia #Lymphoma #Myeloma #SickleCellDisease #OrganTransplantRejection #GraftVersusHostDisease #GVHD #BARDA #ASPR #CBRN #NuclearEmergencyPreparedness #Longevity #Aging #Frailty #ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #ViralPodcast #STEM #Innovation #Technology #Science #ResearchSupport the show

Episode 184: Multiple Myeloma BasicsSub-Interns and future Drs. Di Tran and Jessica Avila explain the symptoms, work up and treatment of multiple myeloma. Written by Di Tran, MSIV, Ross University School of Medicine; Xiyuan Yang, MSIV, American University of the Caribbean. Comments by Jessica Avila, MSIV, American University of the Caribbean. Edits by Hector Arreaza, MD.You are listening to Rio Bravo qWeek Podcast, your weekly dose of knowledge brought to you by the Rio Bravo Family Medicine Residency Program from Bakersfield, California, a UCLA-affiliated program sponsored by Clinica Sierra Vista, Let Us Be Your Healthcare Home. This podcast was created for educational purposes only. Visit your primary care provider for additional medical advice.Di: Hi everyone, this is Di Tran, 4th year medical student from Ross university.  It's a pleasure to be back.  To be honest, this project is a part of teamwork of two medical students, myself and another 4th year, her name is XiYuan.  She came from the AUC. Unfortunately, due to personal matters she was unable to make it to the recording today which makes me feel really sad. Jessica: My name is Jessica Avila, MSIV, American University of the Caribbean.Di: The topic we will present today is Multiple Myeloma. Multiple myeloma is typically a rare disease and it's actually a type of blood cancer that affects plasma cells in the bone marrow.Jessica: Let's start with a case: A 66-year-old male comes to his family doctor for an annual health checkup. He is not in any acute distress but he reports that he has been feeling tired and weaker than usual for the last 3 months. He also noticed that he tends to bruise easily. He has a history of arthritis and chronic joint pain, but he thinks his back pain has gotten worse in the last couple of months. Upon checking his lab values, his family doctor found that he has a calcium level of 10.8 and a creatinine level of 1.2, which has increased from his baseline. Given all that information, what do you think his family doctor is suspecting? And what kind of tests she can order for further evaluation?Di: Those symptoms sound awfully familiar – are we talking about the CRAB? You know, the diagnostic criteria for Multiple Myeloma.Jessica: Exactly! Those are called “myeloma-defining events.” Do you remember what those are?Di: CRAB criteria comes in 4 flavors.  It's HYPERCALCEMIA with >1mg/dL, RENAL INSUFFICIENCY with serum creatinine >2mg/dL, ANEMIA with hemoglobin value 10% plasma cells, PLUS any one or more of the CRAB features, we can make the official diagnosis of multiple myeloma. Di:  Before we go deeper, let's back up a little bit and do a little background.  So, what do we know about the immunoglobulins, also known as antibodies? Back from years of studying from medical school, we know that the plasma cells are the ones that producing the antibodies that help fight infections.  There  are various kinds that come with various functions.  Each antibody is made up of 2 heavy chains and 2 light chains.  For heavy chains, we have A, D, E, G, M and for light chains we have Kappa and Lambda.Jessica: Usually, the 5 possible types of immunoglobulins for heavy chains would be written as IgG, IgA, IgD, IgE, and IgM.  And the most common type in the bloodstream is nonetheless the IgG. Di: What is multiple myeloma? In myeloma, all the abnormal plasma cells make the same type of antibody, the monoclonal antibody.  The cause of myeloma is unknown, but there are lots of studies and evidence that show a number of potential etiologies, including viral, genetic, and exposure to toxic chemicals, especially the Agent Orange, which is a chemical used as herbicide and defoliant. It was used as a chemical warfare by the U.S. military during the Vietnam War from 1961 to 1971.Jessica: We need to order some specific blood tests to see if there is elevated monoclonal proteins in the blood or urine. So, to begin with we'll need to take a very thorough history and physical exam. Next, we'll do labs, such as CBC, basic metabolic panel, calcium, serum beta-2 microglobulin, LDH, total protein, and some not so common tests: serum protein electrophoresis (SPEP), immunofixation of blood or urine (IFE), quantitative immunoglobulins (QIg), serum free light chain assay, and serum heavy/light chain ratio assay.If any of the results is abnormal, we should consider referring our patient to an oncologist.Di: Interesting! I read that Multiple Myeloma symptoms vary in different patients.  In fact, about 10-20% of patients with newly diagnosed myeloma do not have any symptoms at all.   Otherwise, classic symptomatic presentations are weakness, fatigue, increased bruising under the skin, reduced urine output, weakened bones that is likely prone to fractures, etc. And if multiple myeloma is highly suspected, a Bone Marrow biopsy should be done with testing for flow cytometry and fluorescent in situ hybridization (FISH). Actually, if any of the “Biomarkers of malignancy (SLIM)” is met we can also diagnose multiple myeloma even without the CRAB criteria. Jessica: The diagnosis is made if one or more of the following is found: >= 60% of clonal plasma cells on bone marrow biopsy, > 1 lytic bone lesion on MRI that is at least 5mm in size, or a biopsy confirmed plasmacytoma. Di: Imaging comes in at the final step especially if we able to find one or more sites of osteolytic bone destruction > 5mm on an MRI scan.Jessica: What if the bone marrow biopsy returns > 10% of monoclonal plasma cells, but our patient doesn't have either the CRAB or the Biomarker criteria? Di: That's actually a very good question, since Multiple Myeloma is part of a spectrum of plasma cell disorders. That's when smoldering myeloma comes into play. It is a precursor of active multiple myeloma. Smoldering myeloma is further categorized as high-risk or low-risk based on specific criteria.A less severe form is called Monoclonal Gammopathy of Undetermined Significance, or simply MGUS, with < 10% bone marrow involvement. Those are diagnoses we give once we rule out actual multiple myeloma, which are defined by the amount of M-protein in the serum.Jessica:  When to get started on treatment? Multiple Myeloma is on a spectrum of plasma cells proliferative disorders, starting from MGUS to Smoldering Myeloma, to Multiple Myeloma and to  Plasma Cell Leukemia.  Close supervision/active watching is enough for MGUS and low risk Smoldering Myeloma. But once it has progressed to high-risk smoldering myeloma or to active Multiple Myeloma, chemotherapy is usually required. Some situations may require emergent treatment to improve renal function, reduce hypercalcemia, and to prevent potential infections.Di: As of 2024, treatment of Multiple Myeloma comprises the Standard-of-Care approved by the FDA. In fact, the quadruple therapy is a combination of 4 different class of drugs that include a monoclonal antibody, a proteasome inhibitor, an immunomodulatory drug, and a steroid. Jessica: They are Darzalex (daratumumab), Velcade (bortezomib), Revlimid (lenalidomide) and dexamethasone.  Other treatment plans for Multiple Myeloma include chemotherapy, immunotherapy, radiation therapy (for plasmacytomas) and stem cell transplants. The patient will also be on prophylaxis acyclovir and Bactrim while on chemotherapy. Sometimes anticoagulants are also considered because the chemo increases the risk of venous thromboembolic events.Di: Although the disease is incurable, but with the advancing of novel therapies and clinical trials patients with multiple myeloma are able to live longer.  Problem is the majority of patients diagnosed with Multiple Myeloma are older adults (>65), the risk of falling is adding to multiple complications of the disease itself, such as bone density loss, pain, neurological compromises, distress and weakness.  Palliative care may come in help at any point in time throughout the course of treatment but is most often needed at the very end of the course. Jessica, can you give us a conclusion for this episode?Jessica: Multiple Myeloma may not be the most common cancer, but we have to be aware of the symptoms and keep it in our differential diagnosis for patients with bone pain, easy bruising, persistent severe headaches, unexplained renal dysfunction, and remember the CRAB: HyperCalcemia, Renal impairment, Anemia and Bone lesions.Even without trying, every night you go to bed a little wiser. Thanks for listening to Rio Bravo qWeek Podcast. We want to hear from you, send us an email at RioBravoqWeek@clinicasierravista.org, or visit our website riobravofmrp.org/qweek. See you next week! _____________________References:International Myeloma Foundation. (n.d.). International Myeloma Working Group (IMWG) criteria for the diagnosis of multiple myeloma. https://www.myeloma.org/international-myeloma-working-group-imwg-criteria-diagnosis-multiple-myeloma Laubach, J. P. (2024, August 28). Patient education: Multiple myeloma symptoms, diagnosis, and staging (Beyond the Basics). UpToDate. https://www.uptodate.com/contents/multiple-myeloma-symptoms-diagnosis-and-staging-beyond-the-basics.University of California San Francisco. (n.d.). About multiple myeloma. UCSF Helen Diller Family Comprehensive Cancer Center. https://cancer.ucsf.edu/research/multiple-myeloma/about Theme song, Works All The Time by Dominik Schwarzer, YouTube ID: CUBDNERZU8HXUHBS, purchased from https://www.premiumbeat.com/.

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Miguel-Angel Perales, MD Guest: Anna Sureda, MD, PhD Unfortunately, the treatment paradigm for acute graft-versus-host disease (aGVHD) has not changed for a couple of decades as steroids remain the first-line treatment.1 However, steroids are not a targeted therapy, and they have many side effects that are not well tolerated by patients, including life-threatening infections.1-3 Given these risks, it is important to know how to manage infections related to immunosuppression and optimize the care of patients with aGVHD. Joining Dr Charles Turck to discuss the current landscape of aGVHD management are Dr Miguel-Angel Perales and Dr Anna Sureda. Dr Miguel-Angel Perales is the Chief of the Adult Bone Marrow Transplantation Service at Memorial Sloan Kettering Cancer Center in New York, and Dr Sureda is the Head of Clinical Hematology at the University of Barcelona in Spain. References: Bell EJ, Yu J, Bhatt V, et al. Healthcare resource utilization and costs of steroid-associated complications in patients with graft-versus-host disease. Transplant Cell Ther. 2022;28(10):707.e1-707.e7. doi:10.1016/j.jtct.2022.04.014 Sullivan PW, Ghushchyan VH, Globe G, Sucher B. Health-related quality of life associated with systemic steroids. Qual Life Res. 2017;26(4):1037-1058. García-Cadenas I, Rivera I, Martino R, et al. Patterns of infection and infection-related mortality in patients with steroid-refractory acute graft versus host disease. Bone Marrow …

The COVID-19 mRNA vaccine generates enough of an antibody response to protect against severe disease for six months. But other vaccines offer years-long — even lifelong — immunity, such as the measles or yellow fever vaccines. Is there a way for scientists to tell how long a person's immunity will last? A team at Stanford Medicine might have found a way to do just that — with the help of some of the cells found in our bone marrow. Questions about vaccines or the respiratory season? Email us at shortwave@npr.org — we'd love to hear from you!Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy

In an episode first reported in 2017, we bring you what may be, maybe the greatest gift one person could give to another. You never know what might happen when you sign up to donate bone marrow. You might save a life… or you might be magically transported across a cultural chasm and find yourself starring in a modern adaptation of the greatest story ever told.One day, without thinking much of it, Jennell Jenney swabbed her cheek and signed up to be a donor.  Across the country, Jim Munroe desperately needed a miracle, a one-in-eight-million connection that would save him. It proved to be a match made in marrow, a bit of magic in the world that hadn't been there before.  But when Jennell and Jim had a heart-to-heart in his suburban Dallas backyard, they realized they had contradictory ideas about where that magic came from. Today, an allegory for how to walk through the world in a way that lets you be deeply different, but totally together. This piece was reported by Latif Nasser.  It was produced by Annie McEwen, with help from Bethel Habte and Alex Overington.Special thanks to Dr. Matthew J. Matasar, Dr. John Hill, Stephen Spellman at CIBMTR, St. Cloud State University's Cru Chapter, and Mandy Naglich.Join Be The Match's bone marrow registry here: https://join.bethematch.orgEPISODE CREDITS: Reported by - Latif NasserProduced by - Annie McEwenwith help from - Bethel Habte, and Alex OveringtonSign-up for our newsletter!! It includes short essays, recommendations, and details about other ways to interact with the show. Sign up (https://radiolab.org/newsletter)!Radiolab is supported by listeners like you. Support Radiolab by becoming a member of The Lab (https://members.radiolab.org/) today.Follow our show on Instagram, Twitter and Facebook @radiolab, and share your thoughts with us by emailing radiolab@wnyc.org.Leadership support for Radiolab's science programming is provided by the Gordon and Betty Moore Foundation, Science Sandbox, a Simons Foundation Initiative, and the John Templeton Foundation. Foundational support for Radiolab was provided by the Alfred P. Sloan Foundation.

Today, Ali and Asif discuss the career of the late great Norm MacDonald. They start off by talking about his early life, his start in comedy and his breakthrough on ‘Saturday Night Live'. They discuss his other projects and then Asif asks Ali about Norm's comedy style and Ali's thoughts on MacDonald's last Netflix comedy special ‘Nothing Special'.  After a brief discussion of Norm's gambling issues, they then discuss how he kept his diagnosis of multiple myeloma a secret for years and what eventually led to his death in 2021.    MacDonald had several stem cell transplants, so in the second half, Ali asks Asif about these. Asif explains how stem cell transplants and bone marrow transplants are the same thing, the history of this procedure and how it is used against cancer. Asif goes over the different types of transplants, how the stem cells are harvested and how one finds a donor. Finally they discuss the complications of stem cell transplants.    The opinions expressed are those of the hosts, and do not reflect those of any other organizations. This podcast and website represents the opinions of the hosts. The content here should not be taken as medical advice. The content here is for entertainment and informational purposes only, and because each person is so unique, please consult your healthcare professional for any medical questions.   Music courtesy of Wataboi and 8er41 from Pixabay   Contact us at doctorvcomedian@gmail.com   Follow us on Social media: Twitter: @doctorvcomedian Instagram: doctorvcomedian   Show Notes: The resurrection of Norm Macdonald: https://theweek.com/articles/646450/resurrection-norm-macdonald  Jim Downey | Full Episode | Fly on the Wall with Dana Carvey and David Spade: https://www.youtube.com/watch?v=yyu6wkXn1cg Jim Downey & Norm Macdonald Were Both Fired From “SNL” | Conan O'Brien Needs A Friend: https://www.youtube.com/watch?v=ZQIFu9QEI9Y Norm Macdonald had one last secret: https://www.washingtonpost.com/arts-entertainment/2022/05/29/norm-macdonald-nothing-special-netflix/ Norm Macdonald from 2011: http://www.wtfpod.com/podcast/repost-norm-macdonald-from-2011 Stem cell transplant: https://cancer.ca/en/treatments/treatment-types/stem-cell-transplant Stem Cell Transplants in Cancer Treatment: https://www.cancer.gov/about-cancer/treatment/types/stem-cell-transplant Hematopoietic Stem Cell Transplantation: https://www.ncbi.nlm.nih.gov/books/NBK536951/

Immune explains how distinct olfactory mucosal macrophage populations mediate neuronal maintenance and pathogen defense, and failure to establish durable SARS-CoV-2-specific plasma cells in the bone marrow long-lived compartment after mRNA vaccination. Hosts: Vincent Racaniello, Cindy Leifer, Steph Langel, and Brianne Barker Subscribe (free): Apple Podcasts, RSS, email Become a patron of Immune! Links for this episode MicrobeTV Discord Server Nasal mucsosal macrophages, neuronal maintenance, and pathogen defense (Mucos Immunol) No long lived memory B cells after SARS-CoV-2 mRNA vaccination (Nat Comm) Time stamps by Jolene. Thanks! Music by Tatami. Immune logo image by Blausen Medical Send your immunology questions and comments to immune@microbe.tv

Ossium Health is trying to solve a huge bone marrow problem in the US. The startup's goal is to build a bone marrow bank to make it easier for patients to get transplants that fully match their genes. So how does Ossium make this bank and how many people could it help? Plus: you can now change your eye color with a new surgery and Spirit Airlines files for bankruptcy. Join our hosts Jon Weigell and Sara Friedman as they take you through our most interesting stories of the day. Follow us on social media: TikTok: https://www.tiktok.com/@thehustle.co Instagram: https://www.instagram.com/thehustledaily/ Thank You For Listening to The Hustle Daily Show. Don't forget to hit Subscribe or Follow us on Apple Podcasts so you never miss an episode! If you want this news delivered to your inbox, join millions of others and sign up for The Hustle Daily newsletter, here: https://thehustle.co/email/  Plus! Your engagement matters to us. If you are a fan of the show, be sure to leave us a 5-Star Review on Apple Podcasts https://podcasts.apple.com/us/podcast/the-hustle-daily-show/id1606449047 (and share your favorite episodes with your friends, clients, and colleagues).

00:46 The role of skull bone marrow in ageingDuring ageing, bone marrow in the skull becomes an increasingly important site of blood-cell production. This is in stark contrast to most bones where the ability of marrow to make blood and immune cells declines. Studies in mice and humans showed that ageing results in skull bone-marrow expanding, and in mice this marrow was more resistant to inflammation and other hallmarks of ageing. The team behind the work hope by understanding this process better it may be possible to help organs become more resistant to ageing.Research Article: Koh et al.08:56 Research HighlightsElderly big brown bats show remarkable resistance to age-related hearing loss, and why search-engine algorithms may not be the main driver steering people towards misinformation.Research Highlight: No hearing aids needed: bats' ears stay keen well into old ageResearch Highlight: Don't blame search engines for sending users to unreliable sites11:38 How to make lead a useful material to date the Solar SystemResearchers have overcome a major hurdle preventing the radioactive isotope lead-205 from being used as a ‘clock' to date the age of the Solar System. 205Pb is made in some stars and thanks to its half life of around 17 million years has been proposed as a potential way to date ancient astronomical processes. However, exactly how much 205Pb can escape a star were unclear, limiting its dating potential. Now, researchers have mimicked the conditions seen in stars to pin down how much 205Pb can escape into space, paving the way for its use as a clock.Research Article: Leckenby et al.19:51 Briefing ChatHow millions of Android smartphones were used to map the Earth's ionosphere, and the ethical implications of a virologist who treated her own cancer.Nature: Google uses millions of smartphones to map the ionosphereNature: This scientist treated her own cancer with viruses she grew in the labSubscribe to Nature Briefing, an unmissable daily round-up of science news, opinion and analysis free in your inbox every weekday. Hosted on Acast. See acast.com/privacy for more information.

In this week's episode we'll learn more about the role of ERG loss-of-function variants in bone marrow failure and hematological malignancies, a proposed pathway linking factor 11 activation to increased vascular permeability during inflammation, and new clinical criteria for diagnosing anemia, defining transfusion-dependence, and evaluating anemia treatment responses in patients with myelofibrosis.Featured Articles:Germ line ERG haploinsufficiency defines a new syndrome with cytopenia and hematological malignancy predispositionCoagulation factor XI regulates endothelial cell permeability and barrier function in vitro and in vivoProposals for revised International Working Group–European LeukemiaNet criteria for anemia response in myelofibrosis

On this episode, Evan is scared of becoming an angry old man he says, right after ranting about decorations he thinks people should "get off their lawn." Kevin takes his kids to another unnecessary doctor's appointment, Evan pays for something he bought and Kevin's family eats Panda Express too much. Los Angeles, come to our LIVE SHOW, October 2nd at 7:30pm at Dynasty Typewriter! Get tix here! The Dumb Dad podcast is also on Youtube. Subscribe here! For more Dumb Dad Pod, follow us on social – https://bit.ly/3t6tE9M We've got DUMB DAD MERCH!  And we're on CAMEO! We'd love to send a message to a dad (or anybody) in your life who needs a Dumb Dad pick-me-up! CHEAT CODES – BETONLINE – Use our Promo Code: BLEAV to receive your 50% Welcome Bonus on your first deposit. Thanks to Chris Verdú for our show music! Check out Verdú on SoundCloud! And thanks to editor, Annie Laferriere. Check her out on instagram!

Each year, 19,000 Australians are diagnosed with blood cancer and about 1,000 of them approach the Australian Bone Marrow Donor Registry looking for a stem cell donor. The registry says Australia is facing a critical shortage of registered stem cell donors from all cultural backgrounds. Lisa Smith is the CEO of the Australian Bone Marrow Donor Registry. She spoke to SBS Macedonian's Ana Kotaleska.

Among the 20 or so Cochrane reviews of treatments for myocardial infarction is one that reached its third update in August 2024. It looks at the effects of stem cells, and we asked new lead author, Peter-Paul Zwetsloot from University Medical Centre Utrecht in the Netherlands to tell us about the importance of the review and the latest findings.

Among the 20 or so Cochrane reviews of treatments for myocardial infarction is one that reached its third update in August 2024. It looks at the effects of stem cells, and we asked new lead author, Peter-Paul Zwetsloot from University Medical Centre Utrecht in the Netherlands to tell us about the importance of the review and the latest findings.

In the summer of 2021, SPC Christian Sutton reluctantly attended a punk rock concert and was intrigued by a bone marrow registration table there. Inspired, he created Operation Ring the Bell, a series of donor drive events that has taken place at multiple Army bases and led to thousands of new possible bone marrow donors—and saved lives. Hosts LTC (Ret.) Les Smith and LaSherryn Duncan sit down with SPC Sutton to discuss how his life has been driven by volunteering, how a few Afghan refugees have inspired him, and how his vision turned the Army into a worldwide leader in bone marrow donations. Guest: SPC Christian Sutton, Founder and Lead Coordinator, Operation Ring the Bell Has a member of the Army positively changed your life? Now is your chance to thank them publicly with a shoutout via our Hooah Hotline and have it possibly appear on an upcoming episode of AUSA's Army Matters podcast!   AUSA's Army Matters podcast can also be heard on Wreaths Across America Radio on Monday at 8 pm Eastern  You can find Wreaths Across America Radio on the iHeart Radio app, the Audacy app, and the TuneIn app. Search the word Wreath.    Donate: If you are interested in supporting AUSA's educational programs, such as this podcast, please visit www.ausa.org/donate. Feedback: How are we doing? Email us at podcast@ausa.org. Disclaimer: AUSA's Army Matters podcast primary purpose is to entertain. The podcast does not constitute advice or services. While guests are invited to listen, listeners please note that you are not being provided professional advice from the podcast or the guests. The views and opinions of our guests do not necessarily reflect the views of AUSA.

The OSUCCC-James has one of the largest and most comprehensive blood and bone marrow transplant (BMT) and cellular therapy programs in the country, led by Marco de Lima, MD. “You want to cure everyone, period and we work toward that,” de Lima said, as he explained what drives him to find better treatment options for patients. “That's the motivation and the only currency that matters, and that's helping people.” Dr. de Lima described three new programs designed to help patients in Ohio and beyond: providing bone and blood marrow transplants (BMTs) and chimeric antigen receptor (CAR) T-cell therapy on an outpatient basis; engineering the genetic modifications of the cells used in CAR T-cell therapy inhouse; and a partnership to expand cellular therapy programs in Brazil. In the CAR T-cell process, T cells (the cells that fight cancer) are removed from a patient and reengineered in a lab to make them more efficient in recognizing and killing cancer cells. They are then put back into the patient to do their job. In the past, patients were admitted to the James during BMT and CAR T-cell treatments “and their stay was three to five weeks, in relative isolation,” de Lima explained, adding that “our ability to prevent infections, safer chemotherapies have set the stage where we don't have to admit some patients … We will continue to offer inpatient options but will expand the option of coming here daily instead of being admitted to the hospital.” About 20 patients have undergone CAR T-cell treatment on an outpatient basis already. “Of these, 40 percent never needed admission to the hospital and the other 60 percent had their admission times dramatically reduced,” de Lima said. “We want to increase the percentage who will never see the inside of a hospital.” In the past, it took up to two months to send and receive back a patient's re-engineered T cells from labs located throughout the country. “That's too long,” de Lima said and then explained that the OSUCCC – James can now re-engineer the T cells inhouse. “We've currently treated 14 patients in a clinical trial and it's taken us seven days from collecting the cells to giving them back to the patient,” he said. Dr. de Lima also described a partnership with Caring Cross (an organization devoted to providing medical services to underserved populations around the world) and Brazilian health officials. Members of de Lima's team at the James will provide the technical expertise and training to create mobile clean rooms in Brazil that will re-engineer cells for CAR T-cell treatment. “This is a very ambitious program to provide CAR T-cell for free within the Brazilian healthcare system,” de Lima said.

Dr. Paul Szabolcs trained at Semmelweis University School of Medicine in Budapest. He completed his residency at Bellevue Hospital/NYU Medical Center and was Chief Fellow at Sloan Kettering Cancer Center in New York City. He completed postdoctoral fellowships at Memorial Sloan Kettering in Molecular Biology and at Rockefeller University in Physiology and Cellular Immunology. He has been Chief of the Blood and Marrow Transplantation and Cellular Therapies division at the UPMC Children's Hospital of Pittsburgh since 2011. Dr. Szabolcs has dedicated his career to developing effective “reduced-intensity” chemotherapy regimens for patients in need of a blood or bone marrow transplant, especially children with rare immune-system defects and degenerative brain diseases.

This type of animal fat, housed inside bones, lends silky richness to soups, stews, and simple toast -- and eating it may be how humans evolved in the first place. Anney and Lauren celebrate the science and history of bone marrow.See omnystudio.com/listener for privacy information.

Melissa Rodger's then 9 year old daughter Chloe  had a lingering cold in July of 2022 and was told by a doctor that her cold was just a product of "back to back" viruses. Not too long after that Chloe was dehydrated and this time she was sent to a hospital emergency room where she was quickly diagnosed with Acute Myeloid Leukemia. Chloe had to undergo 2 Bone Marrow transplants with first, Melissa, and then her father Luke being her donors. Today Chloe is back in school, doing very well, and hopes to graduate from 6th grade when the academic year ends in December. Melissa will also talk about her own hard fought battles with Anxiety on today's podcast. 

Bone marrow stimulation (BMS) techniques such as microfracture, nanofracture, and the crimson duvet procedure expose the bone marrow of the proximal humerus to the rotator cuff tendon footprint. The effect of performing BMS on tendon healing is a subject of interest.   In conclusion, the healing rate of rotator cuff repair was similar, regardless of whether BMS was performed or not. Additionally, there was no significant difference in postoperative patient-reported outcome scores, range of motion, and complications.   Click here to read the article.

The James Cancer and Aging Resiliency (CARE) clinic is a leader in treating older cancer patients. Patients have been treated with blood and bone marrow transplants (BMTs) for more than 40 years, but, initially, only younger patients were eligible. “There was a bar set as low as 40-years-old when this was a brand-new technology,” said Sarah Wall, MD, MPH, a James hematologist who specializes in treating patients with blood cancers. “Then it was 55 and 60 and 65 and now there is no official upper-age cutoff … it comes down to the individual patient.” In this episode, Wall explains the basics of BMTs. “There are two types, autologous, where a patient gets their own stem cells back, and allogeneic, in which we use donor cells,” she said. Improvements in the drugs used to treat graft-versus-host-disease (GVHD), which can occur in allogenic BMTs, have “really expanded the pool of donors for older adults who may only have siblings who are deceased or have had cancer themselves previously or some other disease that would make them ineligible,” Wall explained. “We have better drugs to prevent graft-versus-host-disease and to treat it when it does happen.” Several patients 70 and older have been treated with BMTs at the James. Wall said her oldest BMT patient is 80. “I have a [group] of the first three gentlemen 70 and older who I treated with a transplant all coming up to their five-year anniversary,” Wall said. “It's a testament to them and to their families and caregiver support that they got through this. We're the scaffolding they build this support on … and it's very rewarding to be part of this and especially to open doors for people who thought they were closed.”

Dr. Guy Handley, Assistant Professor of Medicine with the Division of Infectious Diseases, USF Morsani College of Medicine, provides an overview of Human Herpesvirus 6 in Stem Cell Transplant Patients. Dr. Handley uses clinical cases to describe several scenarios related to HHV6 infection. Topics discussed include background, HHV6 latency, reactivation, clinical presentation, encephalitis, treatment strategies, and outcomes. Guidelines for HHV care are also discussed. Dr. Handley closes by discussing controversies and future directions in HHV6 management.

Ryan Soileau's son Henry had a heart rate of 250 when he was 6 weeks old in February of 2020 when he was taken to the emergency room by his mom and Ryan's wife Ashley. It was discovered that Ryan was suffering from Bone Marrow failure which has a one in a million chance of happening. Remarkably, Ryan is now well on his way to leading a healthy life as his Bone Marrow has recovered on its own and the Bone Marrow transplant that the doctors at St. Jude thought he would need, has been taken off the table and Henry is feeling as well as possible, some 4 years after his original diagnosis. 

So you thought you were safe because your CT scan shows lots of bone for your dental implant? Think again.

Listen to this powerful episode with Christine Anastos as we dive deep into the importance of peer support for caregivers and cancer patients. We're excited to share the Cancer Buddy app with you—a game-changing platform that connects individuals to share experiences and access resources. The Bone Marrow and Cancer Foundation's support is just a click away, helping you find financial assistance and counseling. Whether you're seeking connection, resources, or support, Cancer Buddy's got you covered. Tune into our latest episode to learn more about how this tool can transform your caregiving life, and don't miss out on bringing support right into the palm of your hand. Find transcrips and links at https://www.loveyourcaregivinglife.com/blog

Christina Merrill on why and how she developed CancerBuddy Being diagnosed with cancer or supporting a friend or family member through a cancer diagnosis can be a lonely thing. Luckily there is a new app that's trying to change that. This week, Chris and Gina sit down with Christina Merrill, the President and CEO of the Bone Marrow and Cancer Foundation and the creator of the CancerBuddy app, to talk about why she wanted to develop this app. She shares why support systems can be so life changing for cancer patients and explains how a dating experience informed the way she developed the app.Links: CancerBuddy CancerBuddy - Apple StoreCancerBuddy - Google PlayBone Marrow and Cancer FoundationSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

On today's episode of The Queen of Pep Talks Podcast, Jessica is filling you in with all things new and exciting in her personal life.  Updates include her 2024 body transformation journey, decorating things in the house and her struggles with power tools, and Chris' potential opportunity to donate bone marrow! XOLinks/Resources:Join the EXCLUSIVE Pep Talks Membership!Register for the NEW Freebie Friday emails!Sign up for the JJXO Weekly Newsletter.Join the FREE JJXO Facebook Community.Read my book "Battle for Growth".Need a Workout Plan? Get mine hereFollow the Inspiration on Instagram

This week on Inside the Headset – Presented by CoachComm, we sit down with Ben Gibboney, the defensive coordinator at Carnegie Mellon. In this conversation, Coach Gibboney discusses how he got his start in the coaching profession, his unique journey to where he is today, and being selected as the 2023 Division 3 Assistant Coach of the Year by the AFCA. Coach Gibboney helped the Tartans to a 10-1 record in the 2023 season.   Follow Coach Gibboney and Carnegie Mellon football on social media here:   @CoachGibboney & @TartanFB  Show Notes:   1:05 Introduction  1:33 When did you decide to become a football coach?   3:49 How did you go about finding your first coaching opportunity?   5:43 What was it like coaching with your father?   6:58 Transition to Shippensburg   8:28 Experience taking time away from coaching   10:25 Trying to find a coaching job while being out of the profession  12:13 Balancing life as a part-time coach while also having another job  15:34 Leveraging your jobs to prepare you for future jobs  17:38 Transition from part-time coach to full time defensive coordinator  20:03 Replacing a well-known and well-respected long-time coach  22:24 Working through kinks as a first-time coordinator  25:21 How did you work to improve your craft as a coach?  27:39 What advice would you give to your younger self?  29:20 Working with Bone Marrow foundations at Carnegie Mellon  31:31 Being named the AFCA's 2023 D3 Assistant Coach of the Year  35:25 Conclusion   

Maj. Ashley "Ash" Holzmann is a Psychological Operations Officer with operational experience in South / Central America, the Indo-Pacific, and the Middle East. He serves in the 1st Special Warfare Training Group at the United States Army Special Warfare Center and School.  Sgt. Maj. Derek Riley is one of the most experienced Civil Affairs Noncommissioned Officers in the Army Special Operations Regiment. He has incredible deployment experience and serves the Proponency at the United States Army Special Warfare Center and School. If you are currently serving, please consider signing up to get on the list for bone marrow donations:https://www.salutetolife.org/ Follow Chris and his efforts on their Instagram page:https://www.instagram.com/operationringthebell/ If you want to read more inspiring coverage of what Chris and his teammates have achieved go here:https://taskandpurpose.com/news/fort-bliss-bone-marrow-guy/ The Official Podcast of the United States Army Special Warfare Center and School!USAJFKSWCS selects and trains all Army Special Forces, Civil Affairs, and Psychological Operations soldiers.  Please visit our website at: https://www.swcs.mil. Be sure to check us out and follow us at:* https://www.facebook.com/jfkcenterandschool* https://www.instagram.com/u.s.armyswcs/* https://www.youtube.com/c/USAJFKSWCS/videosPlease like, subscribe, and leave a review! And if you enjoyed this, become a member of the underground by sharing with at least one other person. Word-of-mouth is how movements spread.

This Week's Panel - Big Ell, KooshMoose, rawkerdude This Week's Discussion - With rumors that Microsoft is developing a handheld gaming device we want to know if you would be interested in buying one? What features would you like to see? - wildwest08 Show Discussion: Panelist wildwest took a must needed birthday break off. rawkerdude was up to the task to take his precious spot, and immediately provided commentary on the intro to his new favorite game, Strong Moon. https://youtu.be/o1BT5VCWZOs (Warning. NSFW!) Ell complained about Marvel Ultimate Alliance. It won't be the last time. Koosh took in some new Game Pass hotness. Little rawker: The Games Master then gave Koosh and Ell a surprise! Listen to the ENTIRE episode please! Ranking of Rats - Approximately six years ago the achievement gods sent down from on high a rat. This rat was to be called Ratalaika and it was bountiful. It flourished in all ways Gamerscore and served up over 250 samplings for achievement hunters to partake in. Waka and Elroy have sipped, nay I say indulged in the bountiful harvest of Ratalaika and get together to reflect on which five offerings left the best taste in their respective mouths, occasionally tasting like Bone Marrow oddly enough. It is top 5 Ratalaika titles as regaled by Waka and Elroy. (1:31:50) Games Mentioned: Koosh - A Little to the Left rawker - Bravery and Greed AH101 Podcast Show Links - https://tinyurl.com/AH101Links Year of the Veiner spreadsheet - https://docs.google.com/spreadsheets/d/1VkAvMjmVmXLjRWS61eoMimaoovUz7fr7uPsD6DQPIz4/edit?usp=sharing Intro music provided by Exe the Hero. Check out his band Window of Opportunity on Facebook and YouTube

Robert Ang, CEO of Cambridge, Mass.-based Vor Bio, on using CRISPR gene editing to alter bone marrow transplants and improve treatment of acute myeloid leukemia.

Supplements are meant to supplement a healthy lifestyle, not act as a bandaid to mitigate poor lifestyle choices. While choosing whole foods sources to get certain nutrients is ideal instead of supplements, sometimes we can't make the best choices due to our modern world or environment.  In this episode, I share 6 supplements that I take daily for optimal health, the benefits of these supplements, my go-to brands, and how much I take daily.   In this episode, I discuss: 01:30 - The critical role of sodium in our health, debunking of the misconception that excessive sodium leads to cardiovascular diseases 09:23 - The different types of magnesium salts and their specific advantages 13:18 - Creatine for muscle mass and brain health 15:15 - ION Gut Support, a unique supplement that is sourced from ancient soil and contains bacterial metabolites that can help with gut health and immunity. 20:09 - How bovine colostrum dramatically improves gut health, boosts immune support, and also improves exercise performance 23:30 - The nutritional benefits of beef organs and the importance of maintaining natural ratios when consuming organ supplements   Learn more from Michael Kummer: Use code “primalshift” to save 15% on your order at https://shop.michaelkummer.com/ Website: https://michaelkummer.com/ Instagram: @mkummer82   Resources: Salt (Sodium) Sodium is just one of the minerals important for optimal electrolyte balance. That's why we like LMNT: https://michaelkummer.com/go/lmnt Redmond and Oryx are the salt brands we use. Salts that are unprocessed and contain trace minerals: https://michaelkummer.com/go/realsalt Urinary sodium and potassium excretion and risk of cardiovascular events: https://pubmed.ncbi.nlm.nih.gov/22110105/ Magnesium Different types of magnesium salts: Citrate → constipation Sulfate → relaxation Threonate → cognition Taurate → heart health Chloride → digestion Malate → muscles Glycinate → sleep CALM from Natural Vitality (magnesium carbonate): https://amzn.to/49OysWx Magnesium Breakthrough from BiOptimizers (mix of different types of magnesium. Code MK10 for 10% off): https://michaelkummer.com/go/bioptimizersmagnesium Creatine Found in meat. Carnivores may not need it (1lb of beef has 1-2 grams of creatine), but it won't hurt. We use Creatine Monohydrate from Bulk Supplements: https://amzn.to/47rkOal ION Gut Support ION's humic extract is US-sourced from ancient soil (roughly 60 million years old!) and contains a blend of bacterial metabolites (fulvate) as well as less than 1% of a variety of trace minerals and amino acids.  We use it while traveling and during the colder seasons of the year. They also have a nasal spray. ION* Gut Support: https://michaelkummer.com/go/restore Also available for pets Bovine colostrum Colostrum is the first milk that mammals produce when giving birth. Full of micronutrients, including: lactoferrin, growth factors, immunoglobulins, lysozyme Immune support: reduced the incidence of complications and hospital admissions (related to the flu) by 300%: https://pubmed.ncbi.nlm.nih.gov/17456621/ Additional resources: https://michaelkummer.com/health/bovine-colostrum-benefits/ Top 4 Reasons You Should Supplement with Colostrum (Based on Science): https://youtu.be/HcdguwrV8aE Product we use: Equip Core Colostrum during the colder time of the year. Code MK15 for 15% off at https://michaelkummer.com/go/equipcorecolostrum Freeze-dried beef organs My wife and I founded MK Supplements in 2021 to provide a convenient source of regeneratively raised and 100% grass-fed beef organs for the entire family. My regimen: Full serving of Beef Organs, half a serving of Bone & Marrow and half a serving of Heart & Spleen. Wife does the same. The kids (10 and 8) get Half a serving of each. Use code PRIMALSHIFT for 15% off at https://shop.michaelkummer.com/products/freeze-dried-beef-organs?selling_plan=689239851324

EP. 452 — Check out our Anik & Florian Merch on jonanik.com  FIRST, JA & KenFlo discuss the major headlines in MMA after the UFC Austin event as they try to forecast the UFC Lightweight Division and discuss the noteworthy referee mistakes from this past weekend's card. THEN, the boys chat with show staple Ray Longo on the state of MMA, his upcoming movie role OR Vegas trip, what the future holds for former UFC Champion Aljamain Sterling and much more! AFTER, Jon & Brian Petrie look to cap their win for 2023 in “The Main-Event Challenge” with BIG GUN and BAD ANIK going toe-to-toe with KenFlo & Bone Marrow. BP joins the show to give picks against Kenny Florian for the UFC's 83rd Vegas show, aptly named #UFCVegas83.  RATE AND REVIEW THE SHOW ON iTUNES & AUDIO PLATFORMS! ON TODAY'S SHOW (00:00:00) - OPENING - #AnikFlorianPodcast  (00:02:21) - HEADLINES with @Jon_Anik, @KennyFlorian  (00:28:15) - RAY LONGO MINUTE: @RAYLONGOMMA (01:08:22) - MAIN-EVENT CHALLENGE with @BrianPetrieMMA (01:34:19) - OUTRO (Closing Thoughts) OFFICIAL APPAREL WEBSITE: JONANIK.COM

Immune reveals the total mass (1.2kg), number (1.8 trillion), and distribution of immune cells in the human body, with macrophages contributing nearly 50% of the total cellular mass. Hosts: Vincent Racaniello, Cynthia Leifer, and Brianne Barker Subscribe (free): Apple Podcasts, Google Podcasts. RSS, email Become a patron of Immune! Links for this episode MicrobeTV Discord Server Immune cells in the human body (PNAS) Letters read on Immune 73 Time stamps by Jolene. Thanks! Music by Steve Neal. Immune logo image by Blausen Medical Send your immunology questions and comments to immune@microbe.tv